haylaavo

PDPL

PDPL · NSE · inactive
2.90
+0.05 (+1.75%)
as of 21 Aug 2023 close
Open
2.70
High
2.90
Low
2.70
Prev close
2.85
52w high
4.80
21 Oct 2022
52w low
2.70
21 Aug 2023
VWAP
2.86
Delivery %
—
n/a
Volume 1,063 · turnover ₹3,000 · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 19 Aug 2010
Series
BE
F&O
No
Status
Inactive since 02 Apr 2019

Source: NSE equity master · as of 01 Apr 2019

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 03:08 IST
  • 10 Aug 2024 19:25
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Committee Meeting to be held on August 12, 2024.

    PDF · -
  • 10 Aug 2024 19:10
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on August 09, 2024.

    PDF · -
  • 13 Jul 2024 11:36
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on July 12, 2024.

    PDF · -
  • 07 Jun 2024 19:12
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on Jun 07, 2024.

    PDF · -
  • 06 Jun 2024 16:18
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Committee Meeting to be held on Jun 07, 2024.

    PDF · -
  • 01 Jun 2024 13:51
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on May 29, 2024.

    PDF · -
  • 16 May 2024 11:17
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on May 14, 2024.

    PDF · -
  • 15 May 2024 11:00
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on May 11, 2024.

    PDF · -
  • 25 Apr 2024 18:00
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on April 24, 2024.

    PDF · -
  • 30 Mar 2024 12:25
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 28 Mar 2024 16:21
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on March 26, 2024.

    PDF · -
  • 15 Mar 2024 18:14
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on March 14, 2024.

    PDF · -
  • 13 Mar 2024 18:31
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Committee Meeting to be held on March 14, 2024.

    PDF · -
  • 20 Jan 2024 11:33
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on January 19, 2024.

    PDF · -
  • 17 Jan 2024 11:10
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Committee Meeting held on January 15, 2024.

    PDF · -
  • 27 Dec 2023 15:28
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 30 Jun 2022 15:14
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Closure of trading window

    PDF · -
  • 14 Jun 2022 18:03
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about related party transaction for the period ended March 2022

    PDF · -
  • 31 May 2022 17:28
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Newspaper Advertisements for Annual Audited Financial Results for the Quarter and Financial Year ended on 31st March, 2022.

    PDF · -
  • 31 Mar 2022 12:25
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Closure of trading window from Thursday, March 31, 2022 till 48 hours after the declaration of Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2022.

    PDF · -
  • 15 Feb 2022 17:46
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication of Un-audited Financial Results for the Quarter ended 31st December,2021

    PDF · -
  • 05 Feb 2022 13:44
    Compliance

    Parenteral Drugs (India) Limited hereby informs the stock Exchange about Copy of Newspaper Publication related to completion of dispatch of EOGM notice as on 04.02.2022 and matters incidental thereto.

    PDF · -
  • 03 Feb 2022 18:12
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication dated 03.02.2022 for the notice of Extra ordinary .

    PDF · -
  • 14 Jan 2022 14:15
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 08 Dec 2021 17:02
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about related Party Transactions

    PDF · -
  • 15 Nov 2021 12:30
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding publication of Unaudited Financial results for the Quarter and half year ended on 30th September, 2021 in newspaper

    PDF · -
  • 14 Oct 2021 17:36
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 03 Sept 2021 16:07
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication for notice of 37th Annual General Meeting

    PDF · -
  • 01 Sept 2021 17:12
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication relating to Public Notice of 37th Annual General Meeting.

    PDF · -
  • 12 Aug 2021 14:51
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results for the Quarter ended 30th June , 2021

    PDF · -
  • 26 Jul 2021 18:19
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about related Party Transactions on consolidated basis under Regulation 23(9) of SEBI(Listing Obligations and Disclosure Requirements) Regulation 2015 for the half year ended 31st March, 2021

    PDF · -
  • 16 Jul 2021 18:09
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 24 Apr 2021 11:44
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 15 Feb 2021 12:46
    Compliance

    Parenteral Drugs (India) Limited hereby submits clippings of Newspaper Publication of Unaudited Financial Results for the Quarter ended on 31st December, 2020, pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.

    PDF · -
  • 08 Feb 2021 18:15
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication for the meeting of board of directors to consider financial results for the third quarter of the FY 2020-21 pursuant to Regulation 30 & 47 of SEBI (LODR) Regulations, 2015

    PDF · -
  • 29 Jan 2021 12:51
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 08 Dec 2020 18:02
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about related Party Transactions on consolidated basis for the half year ending on 30th September, 2020

    PDF · -
  • 12 Nov 2020 11:44
    Compliance

    Parenteral Drugs (India) Limited hereby submits clippings of Newspaper Publication of Unaudited Financial Results for the Quarter and half year ended on 30th September, 2020.

    PDF · -
  • 05 Nov 2020 12:22
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication regarding notice of Board Meeting

    PDF · -
  • 23 Oct 2020 18:40
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2020

    PDF · -
  • 21 Sept 2020 18:49
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Corrigendum to results of remote e-voting and voting at the 36th Annual General Meeting held on 19th September, 2020 already submitted

    PDF · -
  • 21 Sept 2020 18:47
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Corrigendum to Scrutinizer Report of 36th Annual General Meeting held on 19th September, 2020 already submitted

    PDF · -
  • 29 Aug 2020 17:26
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Newspaper Publication regarding Notice of 36th Annual General Meeting.

    PDF · -
  • 27 Aug 2020 18:07
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about disclosure of Related Party Transactions on consolidated basis for the half year ended on 31st March, 2020

    PDF · -
  • 26 Aug 2020 17:28
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication of public notice of 36th Annual General Meeting.

    PDF · -
  • 26 Aug 2020 17:15
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper clippings for Unaudited financial results for the quarter ended 30th June 2020 published pursuant to Regulation of 47 SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015.

    PDF · -
  • 20 Aug 2020 15:59
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication

    PDF · -
  • 30 Jul 2020 12:07
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication of Annual Audited Financial Results for the quarter and year ended on 31st March, 2020 published pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    PDF · -
  • 24 Jul 2020 16:23
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 27 Apr 2020 15:32
    Compliance

    Parenteral Drugs (India) Limited has informed the Exchange regarding Corrigendum to intimation submitted w.r.t. Acceptance of One Time Loan Settlement proposal on 25th April, 2020

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries